Also trades as: KIMS.BO (BSE) · $vol 1M
KIMS.NS NSE
Krishna Institute of Medical Sciences Limited
1W: -8.0%
1M: -2.9%
3M: -13.4%
YTD: +13.3%
1Y: +0.7%
3Y: +84.2%
5Y: +194.6%
₹740.00 ($7.69)
-6.40 (-0.86%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$39.0B
+30.0% ▲
5Y CAGR: +24.0%
Gross Profit
$21.3B
+13.5% ▲
5Y CAGR: +38.4%
Operating Income
$5.2B
-15.8% ▼
5Y CAGR: +10.6%
Net Income
$2.4B
-37.2% ▼
5Y CAGR: +3.7%
EPS (Diluted)
$6.03
-37.3% ▼
5Y CAGR: +2.7%
EBITDA
$8.2B
-0.5% ▼
5Y CAGR: +16.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $16.5B | $22.0B | $25.0B | $30.4B | $39.0B |
| YoY Growth | +24.1% | +33.1% | +13.7% | +21.5% | +30.0% |
| Cost of Revenue | $6.2B | $15.0B | $10.2B | $21.2B | $17.7B |
| Gross Profit | $10.3B | $7.0B | $14.8B | $9.1B | $21.3B |
| Gross Margin | 62.6% | 31.8% | 59.3% | 30.0% | 54.6% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3.2B | $4.8B | $495M | $477M | $16.1B |
| Operating Expenses | $1.3B | $352M | $495M | $2.8B | $16.1B |
| Operating Income | $4.5B | $4.9B | $14.3B | $19.1B | $5.2B |
| Operating Margin | 27.1% | 22.3% | 57.4% | 62.9% | 13.3% |
| Interest Expense | $160M | $373M | $546M | $903M | $2.0B |
| Income Before Tax | $4.6B | $4.8B | $4.6B | $5.6B | $3.3B |
| Tax Expense | $1.1B | $1.2B | $1.2B | $1.4B | $919M |
| Net Income | $3.3B | $3.4B | $3.1B | $3.8B | $2.4B |
| Net Margin | 20.2% | 15.3% | 12.4% | 12.7% | 6.2% |
| EPS (Diluted) | $8.38 | $8.41 | $7.75 | $9.61 | $6.03 |
| EBITDA | $5.5B | $6.4B | $6.5B | $7.8B | $8.2B |
| Shares Outstanding | 397M | 400M | 400M | 400M | 400M |